(IPS) Ipsos - Ratings and Ratios
Surveys, Polling, Market Research, Data Analytics
Description: IPS Ipsos
Ipsos SA, a French multinational research and consulting firm, operates in the Research & Consulting Services sub-industry. The companys stock is listed as a common stock with the ticker symbol IPS.
To evaluate Ipsos financial health, we can examine its Income Tax Expense on a yearly basis. A thorough analysis of the companys financial statements would reveal its ability to manage tax liabilities and its impact on profitability. Key Performance Indicators (KPIs) such as the Effective Tax Rate (ETR) and tax-adjusted metrics like Return on Equity (RoE) can provide insights into Ipsos tax management efficiency.
Ipsos Market Capitalization stands at approximately €1.66 billion, indicating a mid-cap company. The stocks Price-to-Earnings (P/E) ratio is around 9.40, suggesting a relatively low valuation compared to its earnings. The Forward P/E ratio is even lower at 7.25, implying expected earnings growth. The companys RoE of 25.32% is a strong indicator of its profitability and ability to generate returns for shareholders.
The Research & Consulting Services industry is closely tied to economic drivers such as GDP growth, consumer spending, and business confidence. As a major player in this industry, Ipsos is likely to benefit from growth in these areas. Additionally, the increasing demand for market research and data analytics services, driven by the need for businesses to make informed decisions, is a key growth driver for the company.
To further analyze Ipsos stock performance, we can consider its beta of 0.887, indicating a relatively low volatility compared to the broader market. The companys stock price has fluctuated between €36.69 and €55.07 over the past 52 weeks, with a current price of €38.12. Average trading volume is around 45,838 shares, indicating a moderate level of liquidity.
IPS Stock Overview
| Market Cap in USD | 1,918m |
| Sub-Industry | Research & Consulting Services |
| IPO / Inception |
IPS Stock Ratings
| Growth Rating | 8.51% |
| Fundamental | 84.1% |
| Dividend Rating | 81.6% |
| Return 12m vs S&P 500 | -42.3% |
| Analyst Rating | - |
IPS Dividends
| Dividend Yield 12m | 4.62% |
| Yield on Cost 5y | 9.71% |
| Annual Growth 5y | 29.67% |
| Payout Consistency | 98.0% |
| Payout Ratio | 45.2% |
IPS Growth Ratios
| Growth Correlation 3m | -81% |
| Growth Correlation 12m | -72.8% |
| Growth Correlation 5y | 69.3% |
| CAGR 5y | 13.59% |
| CAGR/Max DD 5y | 0.32 |
| Sharpe Ratio 12m | 0.04 |
| Alpha | -43.89 |
| Beta | 0.781 |
| Volatility | 30.31% |
| Current Volume | 73.4k |
| Average Volume 20d | 41.7k |
| Stop Loss | 35.3 (-3.1%) |
| Signal | -3.03 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (364.2m TTM) > 0 and > 6% of Revenue (6% = 289.8m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 7.16pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 2.55% (prev 14.18%; Δ -11.64pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.21 (>3.0%) and CFO 610.3m > Net Income 364.2m (YES >=105%, WARN >=100%) |
| Net Debt (169.8m) to EBITDA (841.7m) ratio: 0.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (44.1m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 33.39% (prev 19.45%; Δ 13.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 170.5% (prev 87.38%; Δ 83.11pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 32.03 (EBITDA TTM 841.7m / Interest Expense TTM 18.9m) >= 6 (WARN >= 3) |
Altman Z'' 2.84
| (A) 0.04 = (Total Current Assets 1.13b - Total Current Liabilities 1.00b) / Total Assets 2.91b |
| (B) 0.07 = Retained Earnings (Balance) 204.5m / Total Assets 2.91b |
| (C) 0.21 = EBIT TTM 606.9m / Avg Total Assets 2.83b |
| (D) 0.85 = Book Value of Equity 1.14b / Total Liabilities 1.34b |
| Total Rating: 2.84 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.06
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 27.73% = 5.0 |
| 3. FCF Margin 9.97% = 2.49 |
| 4. Debt/Equity 0.27 = 2.46 |
| 5. Debt/Ebitda 0.51 = 2.30 |
| 6. ROIC - WACC 16.91% = 12.50 |
| 7. RoE 25.32% = 2.11 |
| 8. Rev. Trend 67.45% = 3.37 |
| 9. Rev. CAGR 0.0% = 0.0 |
| 10. EPS Trend 32.96% = 0.82 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of IPS shares?
Over the past week, the price has changed by -4.86%, over one month by -10.78%, over three months by -15.15% and over the past year by -32.15%.
Is Ipsos a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IPS is around 34.28 EUR . This means that IPS is currently overvalued and has a potential downside of -5.88%.
Is IPS a buy, sell or hold?
What are the forecasts/targets for the IPS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.6 | 74.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 37.8 | 3.8% |
IPS Fundamental Data Overview
Market Cap EUR = 1.65b (1.65b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 342.5m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 9.3301
P/E Forward = 7.2098
P/S = 0.6701
P/B = 1.1671
Beta = 0.887
Revenue TTM = 4.83b EUR
EBIT TTM = 606.9m EUR
EBITDA TTM = 841.7m EUR
Long Term Debt = 77.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 354.7m EUR (from shortTermDebt, last quarter)
Debt = 431.7m EUR (Calculated: Short Term 354.7m + Long Term 77.0m)
Net Debt = 169.8m EUR (from netDebt column, last quarter)
Enterprise Value = 1.74b EUR (1.65b + Debt 431.7m - CCE 342.5m)
Interest Coverage Ratio = 32.03 (Ebit TTM 606.9m / Interest Expense TTM 18.9m)
FCF Yield = 27.73% (FCF TTM 481.4m / Enterprise Value 1.74b)
FCF Margin = 9.97% (FCF TTM 481.4m / Revenue TTM 4.83b)
Net Margin = 7.54% (Net Income TTM 364.2m / Revenue TTM 4.83b)
Gross Margin = 33.39% ((Revenue TTM 4.83b - Cost of Revenue TTM 3.22b) / Revenue TTM)
Tobins Q-Ratio = 1.52 (Enterprise Value 1.74b / Book Value Of Equity 1.14b)
Interest Expense / Debt = 1.31% (Interest Expense 5.67m / Debt 431.7m)
Taxrate = 26.02% (from yearly Income Tax Expense: 73.7m / 283.3m)
NOPAT = 449.0m (EBIT 606.9m * (1 - 26.02%))
Current Ratio = 1.12 (Total Current Assets 1.13b / Total Current Liabilities 1.00b)
Debt / Equity = 0.27 (Debt 431.7m / last Quarter total Stockholder Equity 1.58b)
Debt / EBITDA = 0.51 (Net Debt 169.8m / EBITDA 841.7m)
Debt / FCF = 0.90 (Debt 431.7m / FCF TTM 481.4m)
Total Stockholder Equity = 1.44b (last 4 quarters mean)
RoA = 12.50% (Net Income 364.2m, Total Assets 2.91b )
RoE = 25.32% (Net Income TTM 364.2m / Total Stockholder Equity 1.44b)
RoCE = 40.04% (Ebit 606.9m / (Equity 1.44b + L.T.Debt 77.0m))
RoIC = 24.16% (NOPAT 449.0m / Invested Capital 1.86b)
WACC = 7.25% (E(1.65b)/V(2.08b) * Re(8.89%)) + (D(431.7m)/V(2.08b) * Rd(1.31%) * (1-Tc(0.26)))
Shares Correlation 5-Years: -70.0 | Cagr: -0.46%
Discount Rate = 8.89% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 78.74% ; FCFE base≈391.9m ; Y1≈483.4m ; Y5≈824.8m
Fair Price DCF = 277.3 (DCF Value 11.97b / Shares Outstanding 43.2m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 67.45 | Revenue CAGR: 0.0%
Rev Growth-of-Growth: -11.14
EPS Correlation: 32.96 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 54.64